Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRAB_eCB2.0 Sensor.

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Cannabinoid receptors (CB₁R and CB₂R) are key targets for endocannabinoids (eCBs) like 2-AG and AEA, influencing numerous physiological processes.
• The recently developed GRAB_eCB2.0 sensor enables real-time monitoring of eCB levels in biological systems.
• Limited characterization exists for GRAB_eCB2.0's response to synthetic cannabinoid agents, including antagonists and allosteric modulators.

Purpose of the Study:

• To expand the pharmacological characterization of the GRAB_eCB2.0 sensor.
• To understand how GRAB_eCB2.0 fluorescence signals change in response to diverse cannabinoid ligands.
• To improve the utility of GRAB_eCB2.0 for in vitro and in vivo cannabinoid research.

Main Methods:

• Utilized the GRAB_eCB2.0 sensor to detect changes in endocannabinoid signaling.
• Administered various synthetic cannabinoid ligands, including antagonists and allosteric modulators.
• Monitored and analyzed alterations in fluorescent signals generated by the GRAB_eCB2.0 sensor.

Main Results:

• Demonstrated distinct fluorescent signal changes in GRAB_eCB2.0 in response to different cannabinoid ligands.
• Provided a more comprehensive understanding of GRAB_eCB2.0's pharmacological profile.
• Established the sensor's responsiveness to a range of cannabinoid receptor modulators.

Conclusions:

• The enhanced characterization of GRAB_eCB2.0 expands its utility for studying cannabinoid receptor pharmacology.
• Results support the use of GRAB_eCB2.0 for real-time monitoring of endocannabinoid system activity.
• This work may facilitate the development of novel cannabinoid-based therapeutics.